Cerebrovascular disease in type 2 diabetes mellitus

Neurology India

Volumn 50, Issue 4, 2002, Pages 380-385

  Dalal, P M ^a   Parab, P V ^a  

^a LILAVATI HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Diabetes mellitus; Stroke; Syndrome X

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; CATECHOLAMINE DERIVATIVE; D DIMER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOPEPTIDE A; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR; IRBESARTAN; LOSARTAN; PANCREAS POLYPEPTIDE; PLACEBO; RAMIPRIL;

ANTICOAGULANT THERAPY; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; CELL MEMBRANE; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC OBESITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFECT; ENDOTHELIUM; ENDOTHELIUM INJURY; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLYCATION; HEALTH CARE COST; HEART MUSCLE ISCHEMIA; HORMONAL REGULATION; HUMAN; HYALINE DEGENERATION; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPEROSMOLARITY; HYPERTENSION; INCIDENCE; INFARCTION; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PATHOGENESIS; PREVALENCE; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SEX DIFFERENCE; STROKE; SYNDROME X; THROMBOCYTE AGGREGATION; TRANSIENT ISCHEMIC ATTACK; TREATMENT PLANNING;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; PREVALENCE; RISK FACTORS;

EID: 0037004926     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Dalal PM : Stroke in the diabetic patient. Journal of Internal Medicine of India 1996; 7: 56-57.
2. Ramachandran A, Snehalatha C, Kapur A et al : High prevalence of diabetes and impaired glucose tolerance in India : National Urban Diabetes Survey. Diabetologia 2001; 44 : 1094-1101
3. Mohan V, Ravikumar R, Shanthi Rani S et al : Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects: The Chennai Urban Population Study (CUPS). Diabetologia 2000; 43 : 494-499
4. Kannel WB, McGee DL : Diabetes and cardiovascular risk factors : The Framingham Study. Circulation 1979; 59 : 8-13.
5. Davis TM, Millns H, Stratton IM et al : Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med 1999; 159 : 1097-1103.
6. Tanizaki Y, Kiyohara Y, Kato I et al : Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama Study. Stroke 2000; 31 : 2616-2622.
7. Ramachandran A, Snehalatha C, Satyavani K et al : Prevalence of vascular complications and their risk factors in type 2 diabetes. JAPI 1999; 47 : 1152-1156.
8. Sridhar GR: Personal Communication. 2001.
9. Caplan LR : Diabetes and brain ischaemia. Diabetes 1996; 45 : S95-S97.
10. Mankovsky BN, Metzger BE, Molitch ME et al : Cerebrovascular disorders in patients with diabetes mellitus. J Diabetes Complications 1996; 10 : 228-242.
11. Bell ET : A postmortem study of vascular disease in diabetes. Arch Pathol 1952; 53 : 444-455.
12. Alex M, Baron EK, Goldenberg S et al : An autopsy of cerebrovascular accidents in diabetes mellitus. Circulation 1962; 25 : 663-673.
13. Kuebler TW, Bendick PJ, Fineberg SE et al : Diabetes mellitus and cerebrovascular disease : Prevalence of carotid artery occlusive disease and associated risk factors in 482 adult diabetic patients. Diabetes Care 1983; 6 : 274-278.
14. Dalal PM : Cerebrovascular disease (CVD) in Type2 Diabetes Mellitus. Stroke (Indian Edition) 2001; 1 : 1-11.
15. Lukovits TG, Mazzone TM, Gorelick TM : Diabetes mellitus and cerebrovascular disease. Neuroepidemiology 1999; 18 : 1-14.
16. Nakajima S, Noguchi T, Taka T et al : A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke. Platelets 2000; 11 : 459-466.
17. Sagel J, Colwell JA, Crook L et al : Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 1975; 83 : 733-738.
18. Tunbridge WMG : Factors contributing to deaths of diabetics under fifty years of age. Lancet 1981; 2 : 569-572.
19. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A et al: Coronary heart disease in young type I (insulin dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 1987; 30 : 144-148.
20. Jensen T, Stender S, Deckert T : Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type I (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 1988; 31 : 142-145.
21. Jones SL, Close CF, Maltlock NM et al : Plasma lipid and coagulation factor concentrations in insulin-dependent diabetic patients with microalbuminuria. BMJ 1989; 298 : 487-490.
22. Rischen-Vos J, Van Der Woode FJ, Tegzess AM et al : Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with nondiabetic patients. Nephrol Dial Transplant 1992; 7 : 433-437.
23. Dalal PM : Neurological complications of cardiac interventions. In : Reviews in Neurology. Mehndiratta MM (ed). Indian Academy of Neurology 2000; 212-229.
24. Dalal PM : Ischaemic strokes: Management in first six hours. Neurol India 2001; 49 : 104-115.
25. Burchfiel CM, Curb JD, Rodriguez BL et al : Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke 1994; 25 : 951-957.
26. Baillie GM, Sherer JT, Weart CW : Insulin and coronary artery disease: Is syndrome X the unifying hypothesis? Ann Pharmacother. 1998; 32: 233-247.
27. Garvey WT, Hermayer KL : Clinical implications of the insulin resistance syndrome. Clin Cornerstone. 1998; 1 : 13-28.
28. Guerrero-Romero F, Rodriguez-Moran M : Proteinuria is an independent risk factor for ischaemic stroke in non-insulin-dependent diabetes mellitus. Stroke 1999; 30 : 1787-1791.
29. Goldstein L, Adams R, Becker K et al : Primary prevention of ischemic stroke. A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001; 103 : 163-182.
30. Dalal PM, Dalal KP, Rao SV et al : Strokes in west-central India: A prospective case control study of 'Risk Factors' (A problem of developing countries). In : Neurology in Europe, eds D Bartko et al. London. John Libbey and Co Ltd. 1989; 16-20.
31. Matsumoto K, Miyake S, Yano M et al : Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischaemic stroke. Diabetes Care 1999; 22 : 1191-1195.
32. Adachi H, Hirai Y, Tsuruta M et al : Is insulin resistance or diabetes mellitus associated with stroke? An 18-year follow-up study. Diabetes Res Clin Pract 2001; 51 : 215-223.
33. Dalal PM : Management of ischaemic strokes in first 24 hours. In : Medicine Update. Das S (ed.) (In Press) APICON 2003.
34. The Steering Committee of the Physicians Health Study Research Group. Preliminary report findings from the aspirin component of the ongoing physicians health study. N Engl J Med 1988; 318 : 262-264.
35. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002; 324 : 71-86.
36. Sivenius T, Laako M, Riekkinen P Sr et al : European Stroke Prevention Study: Effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. Stroke 1992; 23 : 851-854.
37. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000; 355 : 253-259.
38. Hosomi N, Mizushige K, Ohyama H et al : Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus. Stroke 2001; 32 : 1539-1545.
39. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and complications trial. Ann Neurol 1995; 38 : 869-880.
40. Lewis E, Hunsicker L, Clarke W et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Eng J Med 2001; 345 : 851-860.
41. Brenner B, Cooper M, Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Eng J Med 2001; 345 : 861-869.
42. Egger G : Prevention of type 2 diabetes. Prevention needs to reduce obesogenic environments. BMJ 2001; 323 (7319) : 997.